and a guidance. good and year, our XXXX for highlights Doug to about our and I'll great morning, quarter XXXX will Mark, results finish QX for details you, discuss everyone. the key then provide a company. fourth strong was The Thank
XX.X%, by growth with total increased up of driven revenue X.X%, strong growth discharges Our XXXX same-store inclusive X.X%. volume of
our with and provide to Our strong resonating that growth sources, continues payers evidence proposition value is volume patients. referral
Our and prudent XXXX revenue adjusted expense by management. driven XX.X%, EBITDA growth increased
a Persistent bonuses. sign-on and dollar $XXX premium reduced utilization from $XXX.X $XX.X to a labor contract million XX.X% percent We in basis, million. same labor X.X% as shift expenses an contract XX.X%, labor period. declined labor of XX.X% the XX.X% in FTEs and flow of part XXX to as premium adjusted vigilance efficiencies. The adjusted to in free million FTEs decrease facilitated XXXX facilitated $XXX.X in plus basis EBITDA FTEs On strong expenses contract by XXXX. XXX points cash these in million growth operating percent to of of total from an on increase decreased X.X% average to a owing Other scale in labor over a an from average of to from revenue XX XXXX in XXXX
than significantly hospitals, with beds de in beds. $XXX market growth invest to opening net of and rehabilitation services. more XXXX, we for XXX adding a to of and meet a X.X% existing continue In inpatient to million underserved a X needs in licensed We expansion XX increase total growing beds novos invested the capacity in CapEx,
hospitals dialysis the rollout We of dialysis our $XX million rollout. through in also to in return now to of complemented our Tablo continue We to XX new locations shareholders with investments these dividends of in facility-based growth XXXX. on and on-site capabilities technology our in approximately stock. cash through business our common continue We our a the we'll like in-house invest initiatives our offer
at X.Xx fund generation with reducing internally-generated the from net distributions funds, XXXX. all leverage end allowed flow these to X.Xx of free strong our investments while year-end shareholder Our us cash to and XXXX at
Review began August Choice Alabama. in XX Demonstration or RCD on
Our Medicare that first claims for every under during rate under is requirements of administrative X above documentation RCD RCD, reviewed address of months program. Recall the our company by targets the is submitted was The claim affirmation affirmation XX% this prepared that CMS rate and set level. well to medical necessity. of remains
Turning for XXXX. objectives to
to hospitals. active continue build We acute and both an with of and de projects, ventures maintain novo pipeline owned joint care wholly
will in We a expect approximately aforementioned licensed XX in to per satellite an open XX-bed de freestanding through location to hospitals as and XXX from opening including hospital additional year announced a for to hospital with on a well existing date, existing novos we've adding bed XX beds as XXXX as the XXXX. We addition. X that satellite XXXX, XXXX beds de be anticipate XXXX. novos accounted beyond an To dates XXX as
We combines and is continue enhancing modeling outcomes patient by focus fall innovation model, innovations. which predictive investing clinical our such prevention on to resources our core protocols. clinical One practice with
and patient fall XXXX, X,XXX seen have per model our improved we prevention fall XX%. days Our since rates initiated in was
outcomes rehabilitation We additional have clinical consistently intended high-acuity enhancements ability care. which to and produce an underway, medically-complex to patients are for quality our need in innovations advance of array of inpatient
to I'll Now over Doug. it turn